X

Experts

2024: Everything Everywhere All at Once

Usually the first year of a recovery is the strongest, so now's the time to get into making the most…

Confessions of a Day Trader: Battling low volume and more swing than a prime Wasim Akram

Each Monday, Stockhead’s resident day trader gives us a peek at the highs and lows of his trading diary and…

Tim Boreham’s 12 of the best ASX small caps for 2024

Following hours of due diligence with shady broker types at Melbourne’s legendary Mitre Tavern, here are our wild stabs at…

Money Talks: Keep an eye on these tasty precious metal and biotech plays in 2024

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list…

Guy on Rocks: Uranium boom in ’24? We’ll smoke to that…

I have no doubt, and the Cigar Social Climate Change Sceptic Committee is right behind me on this one, that…

Dr Boreham’s End-of-Year ASX Biotech report card

If the biotech sector were a classroom, 2023 would be "patchy but solid effort in trying conditions". And with the…

SUNDAY ROAST: The stocks that lit a fire under our experts this week

Luke Winchester's three stocks for the big Small Caps Revival of 2024, and climate-change advocates best look away, because ...coal.

CRITERION: Missed the Pro Medicus boat? These cheaper alternatives scan well

Have investors in one of Australia’s most dazzling home-grown ASX success stories missed the boat? No. Not really.

Barry FitzGerald: Throw another four stock tips on the barbie, last year’s are cooked

The good news for Garimpeiro is that despite the miserable 2023 performance, he is still cracking it for festive season…

For Die Hard Investors: Luke’s trio of high-risk small caps Most Likely to Survive Nakatomi Plaza in 2024

Luke from Merewether Capital is always wary of a crowded trade - but he reckons small caps are the place…